Conditions & Recovery · Cancer Health Science · October 24, 2026

Immunotherapy Combination Extends Survival in Advanced Endometrial Cancer

Trial of Imfinzi plus Lynparza is first overall survival analysis demonstrating durable benefits beyond delaying disease progression.

Originally published by Cancer Health Science. We curate and add context; they did the reporting.

Related learning